Loading...

Bayer AG

BAYRY•PNK
Healthcare
Drug Manufacturers - General
$10.77
$-0.43(-3.84%)
U.S. Market opens in 7h 53m

Bayer AG (BAYRY) Stock Overview

Explore Bayer AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap43.9B
P/E Ratio-10.46
EPS (TTM)$-1.08
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$11.09
3 Months$19.01
1 Year Target$13.28

BAYRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bayer AG (BAYRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.46 and a market capitalization of 43.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.07%
5-Day Change
-6.10%
1-Month Change
1.37%
3-Month Change
-20.52%
6-Month Change
39.02%
Year-to-Date (YTD) Change
2.40%
1-Year Change
68.65%
3-Year Change
-32.27%
5-Year Change
-33.41%
All-Time (Max) Change
965.38%

Contact Information

https://www.bayer.com
49 214 30 1
Kaiser-Wilhelm-Allee 1, Leverkusen, NaN, 51368

Company Facts

90,587 Employees
IPO DateNov 18, 1996
CountryDE
Actively Trading

Frequently Asked Questions